Sumitomo Pharma Co., Ltd. (SMDPY)
SMDPY Stock Price Chart
Explore Sumitomo Pharma Co., Ltd. interactive price chart. Choose custom timeframes to analyze SMDPY price movements and trends.
SMDPY Company Profile
Discover essential business fundamentals and corporate details for Sumitomo Pharma Co., Ltd. (SMDPY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
18 Nov 2022
Employees
4.98K
Website
https://www.sumitomo-pharma.comCEO
Toru Kimura
Description
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
SMDPY Financial Timeline
Browse a chronological timeline of Sumitomo Pharma Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 May 2025
EPS came in at $6.08 , while revenue for the quarter reached $105.65B , beating expectations by +20.18%.
Earnings released on 30 Oct 2024
EPS came in at -$121.24 , while revenue for the quarter reached $90.07B .
Earnings released on 31 Jul 2024
EPS came in at $40.11 , while revenue for the quarter reached $90.68B .
Earnings released on 14 May 2024
EPS came in at -$496.52 , while revenue for the quarter reached $79.53B .
Earnings released on 31 Jan 2024
EPS came in at -$72.68 , while revenue for the quarter reached $76.96B .
Earnings released on 31 Dec 2023
EPS came in at -$125.77 , while revenue for the quarter reached $82.39B .
Earnings released on 30 Jun 2023
EPS came in at -$97.81 , while revenue for the quarter reached $75.69B .
Earnings released on 31 Mar 2023
EPS came in at -$140.98 , while revenue for the quarter reached $95.28B .
Dividend declared on 30 Mar 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at -$28.24 , while revenue for the quarter reached $140.98B .
Earnings released on 30 Sept 2022
EPS came in at -$96.63 , while revenue for the quarter reached $159.41B .
Earnings released on 30 Jun 2022
EPS came in at $78.30 , while revenue for the quarter reached $159.88B .
Earnings released on 31 Mar 2022
EPS came in at $25.31 , while revenue for the quarter reached $127.96B .
Earnings released on 31 Dec 2021
EPS came in at $24.94 , while revenue for the quarter reached $138.34B .
Earnings released on 30 Sept 2021
EPS came in at $79.66 , while revenue for the quarter reached $162.53B .
Earnings released on 30 Jun 2021
EPS came in at $12.09 , while revenue for the quarter reached $131.20B .
Earnings released on 31 Mar 2021
EPS came in at -$35.33 , while revenue for the quarter reached $121.19B .
Earnings released on 31 Dec 2020
EPS came in at $82.96 , while revenue for the quarter reached $133.26B .
Earnings released on 30 Sept 2020
EPS came in at $47.92 , while revenue for the quarter reached $127.64B .
SMDPY Stock Performance
Access detailed SMDPY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.